Massachusetts Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $197M | Sell |
|
|||||
|
2025
Q2 | $572M | Sell |
|
|||||
|
2025
Q1 | $982M | Sell |
|
|||||
|
2024
Q4 | $922M | Sell |
|
|||||
|
2024
Q3 | $1.35B | Buy |
|
|||||
|
2024
Q2 | $1.29B | Sell |
|
|||||
|
2024
Q1 | $1.17B | Sell |
|
|||||
|
2023
Q4 | $1.48B | Sell |
|
|||||
|
2023
Q3 | $1.35B | Sell |
|
|||||
|
2023
Q2 | $1.39B | Sell |
|
|||||
|
2023
Q1 | $1.27B | Sell |
|
|||||
|
2022
Q4 | $1.19B | Sell |
|
|||||
|
2022
Q3 | $1.26B | Buy |
|
|||||
|
2022
Q2 | $1.22B | Buy |
|
|||||
|
2022
Q1 | $917M | Buy |
|
|||||
|
2021
Q4 | $702M | Buy |
|
|||||
|
2021
Q3 | $571M | Sell |
|
|||||
|
2021
Q2 | $636M | Buy |
|
|||||
|
2021
Q1 | $614M | Buy |
|
|||||
|
2020
Q4 | $623M | Buy |
|
|||||
|
2020
Q3 | $517M | Buy |
|
|||||
|
2020
Q2 | $525M | Buy |
|
|||||
|
2020
Q1 | $292M | Buy |
|
|||||
|
2019
Q4 | $246M | Sell |
|
|||||
|
2019
Q3 | $207M | Sell |
|
|||||
|
2019
Q2 | $356M | Sell |
|
|||||
|
2019
Q1 | $363M | Buy |
|
|||||
|
2018
Q4 | $317M | Buy |
|
|||||
|
2018
Q3 | $355M | Buy |
|
|||||
|
2018
Q2 | $283M | Buy |
|
|||||
|
2018
Q1 | $248M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $60.8M | Sell |
|
|||||
|
2015
Q3 | $58.9M | Buy |
|
|||||
|
2015
Q2 | $67.5M | Buy |
|
|||||
|
2015
Q1 | $52.1M | Sell |
|
|||||
|
2014
Q4 | $82.2M | Buy |
|
|||||
|
2014
Q3 | $57.7M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $5.57M | Sell |
|
|||||
|
2013
Q4 | $5.96M | Sell |
|
|||||
|
2013
Q3 | $6.15M | Sell |
|
|||||
|
2013
Q2 | $6.59M | Buy |
|